More than 40% will consider using secure texting in the next twelve months, while a similar number will use drug, device, or diagnosis information. Nearly half of physicians already use mobile apps to research medication interactions, while more than a quarter use clinical decision support features. ePrescribing, composing clinical notes, and access labs and test results were also common activities conducted through mobile apps.
Patients will become an increasingly important part of the mHealth landscape, as well, with providers moving into Stage 2 of Meaningful Use. Thirty-five percent of provider respondents will use mobile devices to access patient portals used for scheduling and communications, while one in five will embrace patient use of mHealth for remote monitoring and 15% will explore telehealth visits using tablets and smartphones for support. Read more
